Revlimid capsules 5mg, manufactured by Bristol-Myers Squibb, contains Lenalidomide hydrate, which is prescribed for multiple myeloma, myelodysplastic syndromes, follicular lymphoma, and mantle cell lymphoma. This 5mg 1 capsule formulation is identified by YJ code 4291024M1024.
Revlimid capsules 5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
